Pfizer is currently seeking adults 18 to 80 years of age for a dermatomyositis clinical trial. This clinical trial will assess the effectiveness and safety of an investigational study drug compared to placebo. The study drug is a type of drug called a biologic and is given monthly by infusion. The clinical trial is now active, and enrollment is open at multiple sites across the United States. Qualified participants will receive study-related care and study drug (or placebo) at no cost. Learn more here.